AI brief of an SEC Form 8-K · Gentex (GNTX)

Gentex Q4 net sales fall 8% to $541.6 million; 2024 EPS $1.76 vs. $1.84

Mixed Impact 3 of 5 earnings Written later

Gentex reported fourth-quarter 2024 net sales of $541.6 million, down 8% from a year earlier, and diluted EPS of $0.39 versus $0.50. For calendar 2024, net sales rose 1% to a record $2.31 billion, but diluted EPS fell to $1.76 from $1.84. The company also issued 2025 revenue guidance of $2.40 to $2.45 billion, which is a forecast of growth for shareholders to weigh against the weaker fourth quarter and lower profit.

Key points

  • Q4 2024 net sales were $541.6 million, down from $589.1 million in Q4 2023; the company cited a revenue shortfall of approximately $45 to $50 million versus its beginning-of-quarter forecast.
  • Q4 2024 gross margin was 32.5% versus 34.5%, and the quarter included an $8.9 million intangible asset impairment charge.
  • Calendar 2024 net income was $404.5 million versus $428.4 million in 2023.
  • 2025 guidance includes revenue of $2.40 to $2.45 billion and gross margin of 33.5% to 34.5%; the guidance excludes the pending VOXX International acquisition.

The filing

CompanyGentex (GNTX)
Form8-K, current report
Filed with the SECJan 31, 2025, 8:01 AM ET
Accession number0000355811-25-000006

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:01 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 31, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.